Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.64 |
| ▸ | NCF1 | P14598 | 2/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | AURKA | O14965 | 1/20 | 0.51 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | MYC | P01106 | 1/20 | 0.48 |
| ▸ | MAX | P61244 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30199873 | 1.00 | CYP1A2 (0.64) | CYP1A2NCF1L3MBTL1AURKAAURKB | |
| SCHEMBL28129148 | 0.81 | L3MBTL1 (0.60) | CYP1A2NCF1L3MBTL1AURKAAURKB | |
| SCHEMBL9326676 | 0.78 | MYC (0.52) | CYP1A2MEN1KMT2APOLBMYC | |
| SCHEMBL89010 | 0.78 | CYP1A2 (1.00) | CYP1A2NCF1L3MBTL1KMT2APOLB | |
| SCHEMBL64767 | 0.78 | MYC (0.52) | CYP1A2L3MBTL1MEN1KMT2AHTT | |
| SCHEMBL29376440 | 0.78 | MYC (0.52) | CYP1A2L3MBTL1MEN1KMT2AHTT | |
| SCHEMBL29502790 | 0.78 | CYP1A2 (1.00) | CYP1A2NCF1L3MBTL1KMT2APOLB | |
| SCHEMBL5033387 | 0.78 | KDM4E (0.43) | CYP1A2L3MBTL1POLBKDM4EALDH1A1 | |
| SCHEMBL3760247 | 0.78 | LMNA (0.61) | CYP1A2L3MBTL1MEN1KMT2AHTT | |
| SCHEMBL6593684 | 0.78 | CYP1A2 (0.50) | CYP1A2L3MBTL1POLBKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 414 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118791429-A | Preparation method of 4-chloroquinaldine | 湖北省宏源药业科技股份有限公司 | 2024-10-18 | — | — | CN | claimed |
| US-20240269308-A1 | PRODRUGS OF TOPOISOMERASE I INHIBITOR FOR ADC CONJUGATIONS AND METHODS OF USE THEREOF | REGENERON PHARMACEUTICALS, INC. (US) | 2024-08-15 | — | — | US | claimed |
| WO-2024138000-A1 | PRODRUGS OF TOPOISOMERASE I INHIBITOR FOR ADC CONJUGATIONS AND METHODS OF USE THEREOF | REGENERON PHARMACEUTICALS, INC. (US) | 2024-06-27 | — | — | WO | claimed |
| CN-118047720-A | Preparation method of dequalinium chloride | 美享生物科技(海南)有限公司 | 2024-05-17 | — | — | CN | claimed |
| CN-116396653-B | Method for preparing metal-organic polymer coating based on latticed supermolecular monomer | 五邑大学 | 2024-02-09 | — | — | CN | claimed |
| CN-116396653-A | Method for preparing metal-organic polymer coating based on latticed supermolecular monomer | 五邑大学 | 2023-07-07 | — | — | CN | claimed |
| CN-115286622-A | Quinoline ring-containing 1,2, 4-oxadiazole substituted benzamide compound and preparation method and application thereof | 浙江工业大学 | 2022-11-04 | — | — | CN | claimed |
| CN-114034693-A | Combined test paper for detecting urine creatinine urine microalbumin semiquantitative, preparation method and application thereof | 广州达安基因股份有限公司 | 2022-02-11 | — | — | CN | claimed |
| US-20220015363-A1 | SMALL MOLECULE PATHOGEN DISPERSAL AGENT | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2022-01-20 | — | — | US | claimed |
| CN-111704633-A | Mo catalyst and application thereof in preparation of 9, 10-epoxy-1, 5-cyclododecadiene | 万华化学集团股份有限公司 | 2020-09-25 | — | — | CN | claimed |
| WO-1998033786-A1 | ACCELERATED CATALYSIS OF OLEFINIC EPOXIDATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 1998-08-06 | — | — | WO | claimed |
| US-RE35601-E | Delivery device providing beneficial agent stability | ALZA CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| US-5373015-A | Treating hypertension and congestive heart failure | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-12-13 | — | — | US | claimed |
| US-5245035-A | HETEROCYCLIC BORON COMPOUNDS AS INTERMEDIATES FOR ANGIOTENSIN II ANTAGONISTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-09-14 | — | — | US | claimed |
| EP-0539066-A1 | Heterocyclic compounds useful as angiotensin II antagonists | ZENECA LIMITED (GB) | 1993-04-28 | — | — | EP | claimed |
| EP-0495626-A1 | Process for the preparation of tetrazole derivatives | ZENECA LIMITED (GB) | 1992-07-22 | — | — | EP | claimed |
| EP-0495627-A1 | Boron compounds | ZENECA LIMITED (GB) | 1992-07-22 | — | — | EP | claimed |
| EP-0124752-B1 | MIXTURES OF SUBSTANCES WITH GROWTH AND OUTPUT ACCELERATING EFFECT AS WELL AS FEED AND WATERING LIQUIDS WHICH CONTAIN LOW AMOUNTS OF THESE MIXTURES | BASF Aktiengesellschaft (DE) | 1986-07-16 | — | — | EP | claimed |
| US-4496727-A | ORGANIC PIGMENTS; PLASTICS; LACQUERS; INKS; COATINGS; COLOR FASTNESS | CIBA-GEIGY CORPORATION (US) | 1985-01-29 | — | — | US | claimed |
| EP-0065192-B1 | GROWTH-PROMOTING FODDER OR DRINKING LIQUID | BASF Aktiengesellschaft (DE) | 1984-02-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240269308-A1 | PRODRUGS OF TOPOISOMERASE I INHIBITOR FOR ADC CONJUGATIONS AND METHODS OF USE THEREOF | TOP1, TOP2A, QPCT | CYP1A2 1881/4885NCF1 2276/4885L3MBTL1 2490/4885 |
| US-20220015363-A1 | SMALL MOLECULE PATHOGEN DISPERSAL AGENT | RECQL, POLQ, HIRA | CYP1A2 2983/4885NCF1 2308/4885L3MBTL1 1633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.